{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:12:08Z","timestamp":1788455528039,"version":"build-2803163510"},"reference-count":45,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["mBio"],"published-print":{"date-parts":[[2026,3,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>When studying virus neutralization by specific antibodies of the adaptive immune response, serum heat treatment is a standard procedure done to eliminate any non-specific effects by the complement system. Although non-specific, innate immune responses such as these may be relevant in determining infection outcome. We observed extensive variation between negative control donors in their ability to neutralize Ebola virus and other enveloped viruses in the presence of complement. The effect was mediated by the classical pathway of complement activation, with serum IgM the main initiator in a manner that depended on the cell line that produced the virus. To identify the epitope, three monoclonal IgM antibodies were isolated after a neutralization screen and probed against arrayed glycans. The antibodies were found to bind ganglioside GM2, and the test virus was rendered refractory to anti-GM2 neutralization when propagated in the presence of an inhibitor of ganglioside synthesis. Gangliosides and other host membrane moieties are known to be carried by viruses and to aid entry to cells. The findings here suggest that under specific circumstances, such moieties incorporated in lipid envelopes of viruses can be recognized by potently neutralizing IgM antibodies present in the serum of immunologically na\u00efve individuals.<\/jats:p>\n                    <jats:sec>\n                      <jats:title>IMPORTANCE<\/jats:title>\n                      <jats:p>Neutralization, that is, the ability to block infection in cell culture, remains the primary functional attribute of therapeutic antibodies and humoral immune responses against viruses. Beyond direct effects\u2014such as preventing virus attachment to the cell\u2014virus inactivation by antibody-mediated complement deposition or lysis is often considered a type of neutralization. Viral envelope glycoproteins are the main targets of neutralizing antibodies. However, because viruses obtain their membranes from cells in which they replicate, the membranes are known to contain cell-derived markers in addition to virally encoded proteins. Having observed marked individual variance in na\u00efve serum donors\u2019 ability to neutralize Ebola virus and other enveloped viruses, we sought to understand the mechanism. Three IgM monoclonals targeting a cell-derived epitope were isolated. The findings expand on the importance of cellular factors exposed on the virion membrane and suggest that they may be targets of potent antibody-mediated immune monitoring.<\/jats:p>\n                    <\/jats:sec>\n                  <\/jats:sec>","DOI":"10.1128\/mbio.01709-25","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:00:39Z","timestamp":1770991239000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["Monoclonal IgM antibodies mediate potent complement neutralization by targeting cell-derived epitopes on enveloped viruses"],"prefix":"10.1128","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2492-1210","authenticated-orcid":true,"given":"Markus H.","family":"Kainulainen","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qzjvm58","id-type":"ROR","asserted-by":"publisher"}],"name":"Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6051-0254","authenticated-orcid":false,"given":"Jessica R.","family":"Harmon","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qzjvm58","id-type":"ROR","asserted-by":"publisher"}],"name":"Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3398-8628","authenticated-orcid":true,"given":"\u00c9ric","family":"Bergeron","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qzjvm58","id-type":"ROR","asserted-by":"publisher"}],"name":"Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1643-7093","authenticated-orcid":false,"given":"Katherine A.","family":"Davies","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qzjvm58","id-type":"ROR","asserted-by":"publisher"}],"name":"Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention","place":["Atlanta, USA"]},{"name":"Zoonotic and Emerging Disease Research Unit, United States Department of Agriculture, National Bio and Agro-Defense Facility, Agricultural Research Service","place":["Manhattan, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan L.","family":"LeBlanc","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qzjvm58","id-type":"ROR","asserted-by":"publisher"}],"name":"Advanced Diagnostics and Biotechnologies Branch, Division of Core Laboratory Services and Response, Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Clines","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qzjvm58","id-type":"ROR","asserted-by":"publisher"}],"name":"Advanced Diagnostics and Biotechnologies Branch, Division of Core Laboratory Services and Response, Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan L.","family":"Bentz","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qzjvm58","id-type":"ROR","asserted-by":"publisher"}],"name":"Advanced Diagnostics and Biotechnologies Branch, Division of Core Laboratory Services and Response, Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0523-4431","authenticated-orcid":true,"given":"Joel M.","family":"Montgomery","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qzjvm58","id-type":"ROR","asserted-by":"publisher"}],"name":"Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8406-3161","authenticated-orcid":false,"given":"Christina F.","family":"Spiropoulou","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qzjvm58","id-type":"ROR","asserted-by":"publisher"}],"name":"Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-020-02184-w"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00858-w"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00926-1"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00106-19"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.118.1.348"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060838"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.81199-0"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/257612a0"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.144.4.970"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.232137699"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.04.037"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad136"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.1.533"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.1999.tb02462.x"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4165(92)90168-t"},{"key":"e_1_3_4_17_2","first-page":"6154","article-title":"Generation of two murine monoclonal antibodies that can discriminate N-glycolyl and N-acetyl neuraminic acid residues of GM2 gangliosides","volume":"48","author":"Miyake M","year":"1988","unstructured":"Miyake M, Ito M, Hitomi S, Ikeda S, Taki T, Kurata M, Hino A, Miyake N, Kannagi R. 1988. Generation of two murine monoclonal antibodies that can discriminate N-glycolyl and N-acetyl neuraminic acid residues of GM2 gangliosides. Cancer Res 48:6154\u20136160.","journal-title":"Cancer Res"},{"key":"e_1_3_4_18_2","first-page":"5497","article-title":"Gangliosides and sialoglycoproteins carrying a rare blood group antigen determinant, Cad, associated with human cancers as detected by specific monoclonal antibodies","volume":"50","author":"Hiraiwa N","year":"1990","unstructured":"Hiraiwa N, Tsuyuoka K, Li Y-T, Tanaka M, Seno T, Okubo Y, Fukuda Y, Imura H, Kannagi R. 1990. Gangliosides and sialoglycoproteins carrying a rare blood group antigen determinant, Cad, associated with human cancers as detected by specific monoclonal antibodies. Cancer Res 50:5497\u20135503.","journal-title":"Cancer Res"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)37202-2"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.857481"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix584"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.25.15866"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.20.11751"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/gbe\/evx251"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20011500"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-019-0453-2"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.17.5392"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni1113"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2011.07.020"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102107"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5447.2156"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0388-9"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1398.031"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2013.07.041"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030645"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1155164"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01025-13"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2012.08.009"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003232"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2011.03.012"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-024-01637-6"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2004.10.048"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2265660"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.3390\/v13071255"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn316"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot5633"}],"container-title":["mBio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/mbio.01709-25","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/mbio.01709-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:04:12Z","timestamp":1773234252000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/mbio.01709-25"}},"subtitle":[],"editor":[{"given":"Carolyn B.","family":"Coyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,11]]}},"alternative-id":["10.1128\/mbio.01709-25"],"URL":"https:\/\/doi.org\/10.1128\/mbio.01709-25","relation":{},"ISSN":["2150-7511"],"issn-type":[{"value":"2150-7511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"2025-06-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01709-25"}}